⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 29, 2026Oral Diseases

Authors' Reply: “Advances in Antiviral Strategies for Oral Herpes Infections in Immunocompromised Patients”

Nishant Burnase Bikash Kumar P. S. Ashok Kumar Rajathirajan Siva Dharshini Reena Das Anand Barapatre

View at Publisher

Ask AI

Bookmark

Share

Key Points

The aim is to address the advancements in antiviral strategies specifically targeting oral herpes infections in immunocompromised patients.
Review of recent advancements in antiviral treatments for oral herpes.
Discussion of case reports and treatment outcomes in immunocompromised individuals.
Identified several effective antiviral drugs.
Highlighted the need for tailored treatments for immunocompromised patients.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

This reply discusses antiviral strategies for oral herpes infections in immunocompromised individuals, highlighting efficacy implications.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Burnase et al. (2026) studied this question.

synapsesocial.com/papers/69ccb63f16edfba7beb87ee0 https://doi.org/10.1111/odi.70323

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Amenamevir for acyclovir‐resistant genital HSV ‐2 infection in people living with HIVLate-Phase Clinical Trial · 2025 · 2 citations
2Management of oral herpes simplex virus infections: The problem of resistance. A narrative reviewreview · 2023 · 59 citations
3Recommendations for the selection of nucleoside analogues as antihuman herpesvirus drugs: a real-world analysis of reported cases from the FDA adverse event reporting system2024
4Use of short-course oral amenamevir (helicase-primase inhibitor) for the treatment of thymidine analogue-resistant herpes simplex lesions2025
5Combination drug therapy as a strategy to improve the efficacy and safety of treatment of herpes simplex virus infections: potential risks and prospectsreview · 2025

More related papers

An exploratory study of the efficacy and safety of amenamevir for the treatment of herpes zoster in patients receiving immunosuppressive drugs2024
Study of prescription-indication of antivirals for herpesviruses in a Colombian population. A cross-sectional study v12024
Clinical and genotypic characteristics of antiviral-resistant herpes simplex virus 1 and 2 infections: a case series2026

More from Oral Diseases

RIPK3 Promotes Gingival Fibroblast Apoptosis and Periodontal Inflammatory Injury by Impairing MitophagyWed,
Effect of Water Rinsing on Dental Biofilm pH After Exposure to Fermentable Carbohydrate: A Scoping ReviewThu,